A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB AS ADJUVANT TREATMENT FOLLOWING COMPLETE RESECTION AND PLATINUM-BASED CHEMOTHERAPY IN ADULT PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER WITH A HIGH RISK OF RECURRENCE

被引：0
|
作者：
Miguel, Silva L. [1 ]
Pinheiro, B. [2 ]
Carvalho, P. [1 ]
Jovanoski, N. [3 ]
Belleli, R. [3 ]
Abogunrin, S. [3 ]
Alves, P. [1 ,4 ]
Araujo, A. [5 ]
Barata, F. [6 ]
Hespanhol, V [7 ]
da Luz, R. [8 ]
Borges, M. [9 ]
机构：
[1] IQVIA Portugal, Lisbon, Portugal
[2] IQVIA Portugal, Oeiras, Portugal
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
[4] Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[5] Ctr Hosp Univ Santo Antonio, Porto, Portugal
[6] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
[7] Ctr Hosp Univ S Joao, Porto, Portugal
[8] Ctr Hosp & Univ Lisboa Cent, Lisbon, Portugal
[9] Univ Lisbon, Lab Farmacol Clin & Terapeut, Fac Med, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE78
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan
    Chisaki, Yugo
    Nakano, Hajime
    Minamide, Juna
    Yano, Yoshitaka
    CLINICAL DRUG INVESTIGATION, 2023, 43 (11) : 839 - 850
  • [22] Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan
    Yugo Chisaki
    Hajime Nakano
    Juna Minamide
    Yoshitaka Yano
    Clinical Drug Investigation, 2023, 43 : 839 - 850
  • [23] Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer
    Thatcher, N
    Faivre-Finn, C
    Blackhall, F
    Anderson, H
    Lorigan, P
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5051S - 5056S
  • [24] Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer
    Brown, Lisa M.
    Louie, Brian E.
    Jackson, Nicole
    Farivar, Alexander S.
    Aye, Ralph W.
    Vallieres, Eric
    ANNALS OF THORACIC SURGERY, 2016, 102 (04): : 1110 - 1118
  • [25] Recurrence Dynamics After Complete Resection and Adjuvant Chemotherapy in Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer
    Sun, X.
    Men, Y.
    Yang, X.
    Deng, L.
    Wang, W.
    Zhai, Y. R.
    Liu, W., Jr.
    Zhang, T.
    Wang, X.
    Bi, N.
    Lv, J.
    Liang, J.
    Feng, Q.
    Chen, D.
    Xiao, Z.
    Zhou, Z.
    Wang, L.
    Hui, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E453 - E453
  • [26] Cost-Effectiveness of a 14-Gene Risk Score Assay to Target Adjuvant Chemotherapy in Early Stage Non-Squamous Non-Small Cell Lung Cancer
    Roth, Joshua A.
    Billings, Paul
    Ramsey, Scott D.
    Dumanois, Robert
    Carlson, Josh J.
    ONCOLOGIST, 2014, 19 (05): : 466 - 476
  • [27] CLINICAL STUDY ON ENDOSTAR COMBINED PLATINUM-BASED POSTOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Feng, P.
    RESPIROLOGY, 2011, 16 : 178 - 178
  • [28] The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis
    Samson, Pamela
    Patel, Aalok
    Robinson, Cliff G.
    Morgensztern, Daniel
    Chang, Su-Hsin
    Colditz, Graham A.
    Waqar, Saiama
    Crabtree, Traves D.
    Krupnick, A. Sasha
    Kreisel, Daniel
    Patterson, G. Alexander
    Meyers, Bryan F.
    Puri, Varun
    ANNALS OF THORACIC SURGERY, 2015, 100 (06): : 2026 - 2032
  • [29] Investigation of the optimal platinum-based regimen in the postoperative adjuvant chemotherapy setting for early-stage resected non-small lung cancer: a Bayesian network meta-analysis
    Pang, Lan-Lan
    Gan, Jia-Di
    Huang, Yi-Hua
    Liao, Jun
    Lv, Yi
    Ali, Wael Abdullah-Sultan
    Zhang, Li
    Fang, Wen-Feng
    BMJ OPEN, 2022, 12 (06):
  • [30] Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
    Park, Seong Yong
    Lee, Jin Gu
    Kim, Jieun
    Byun, Go Eun
    Bae, Mi Kyung
    Lee, Chang Young
    Kim, Dae Joon
    Chung, Kyung Young
    JOURNAL OF CARDIOTHORACIC SURGERY, 2013, 8
12345